SEC Form 4 · accession 0001225208-19-001829
Cigna Group · CI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven B Miller
Officer — EVP, Chief Clinical Officer
Period of report
Feb 1, 2019
Accepted (ET)
Feb 5, 2019 · 7:05 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001739940
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $.01 Par ValueF1 | Feb 4, 2019 | A | 4,179 | $0.00 | A | 20,311 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Phantom Stock UnitsF2,F3,F4 | $0.00 | Feb 1, 2019 | A | 155 | A | — | — | Common Stock, $.01 Par Value | 155 | 1,119 | D |
Explanation of responses
- F1Total holdings were increased by one share of common stock due to a rounding error on the Form 4 report that was filed on December 26, 2018.
- F2Phantom Stock Units credited under Express Scripts Executive Deferred Compensation Plan.
- F3Upon distribution, each Phantom Stock Unit converts to one share of Cigna Corporation Common Stock.
- F4Basic Company Credit by Cigna Corporation to Participant's account in the Express Scripts Executive Deferred Compensation Plan; the Basic Company Credit is fully vested once credited to the Participant's account.